165 related articles for article (PubMed ID: 23654144)
1. [Respiratory function impairment during treatment of chronic hepatitis C with peginterferon alfa2 and ribavirin. Two cases presentation].
Biedroń-Machura M; Musialik J; Sozańska E; Zbroszczyk M; Baron J; Błońska-Fajfrowska B; Pierzchała W
Wiad Lek; 2012; 65(4):232-8. PubMed ID: 23654144
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonitis after treatment for hepatitis C virus infection.
Botnaru V; Munteanu O; Rusu D
Pneumologia; 2015; 64(1):46-50. PubMed ID: 26016056
[TBL] [Abstract][Full Text] [Related]
3. [Development of sarcoidosis during treatment for chronic hepatitis C with pegylated interferon alfa-2a and ribavirin: case report and literature review].
Cacopardo B; Pinzone MR; Nunnari G
Infez Med; 2013 Mar; 21(1):40-44. PubMed ID: 23524900
[TBL] [Abstract][Full Text] [Related]
4. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
Waltschew A
Pathologe; 2016 Mar; 37(2):184-6. PubMed ID: 26769217
[TBL] [Abstract][Full Text] [Related]
5. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
Foster GR; Zeuzem S; Pianko S; Sarin SK; Piratvisuth T; Shah S; Andreone P; Sood A; Chuang WL; Lee CM; George J; Gould M; Flisiak R; Jacobson IM; Komolmit P; Thongsawat S; Tanwandee T; Rasenack J; Sola R; Messina I; Yin Y; Cammarata S; Feutren G; Brown KK
J Viral Hepat; 2013 Apr; 20(4):e115-23. PubMed ID: 23490379
[TBL] [Abstract][Full Text] [Related]
6. Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.
Slavenburg S; Heijdra YF; Drenth JP
Dig Dis Sci; 2010 Mar; 55(3):579-85. PubMed ID: 19399621
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
Honsová E; Sticová E; Sperl J
Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
[TBL] [Abstract][Full Text] [Related]
8. [Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon].
Moudden MK; Ziadi T; Al Bouzidi A; Ouarssani A; Hadri L; El Baaj M
Rev Pneumol Clin; 2014 Dec; 70(6):362-5. PubMed ID: 25131364
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
10. Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
Tamaki K; Okubo A
World J Gastroenterol; 2015 Jan; 21(3):1009-13. PubMed ID: 25624738
[TBL] [Abstract][Full Text] [Related]
11. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Hunyady B; Kovács B; Battyáni Z
Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
[TBL] [Abstract][Full Text] [Related]
13. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
14. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
Slim J; Afridi MS
Infect Dis Clin North Am; 2012 Dec; 26(4):917-29. PubMed ID: 23083824
[TBL] [Abstract][Full Text] [Related]
15. Side effects of antiviral therapy in hepatitis C virus infection-sarcoidosis - case report.
Teodor D; Teodor A; Grigore L; Jugănariu G; Dorobăţ CM; Miftode E; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1039-43. PubMed ID: 23700885
[TBL] [Abstract][Full Text] [Related]
16. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
17. Interferon-induced sarcoidosis.
Cardoso C; Freire R; Alves A; Oliveira A
BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696628
[TBL] [Abstract][Full Text] [Related]
18. [Pegylated intereferon hematological safety in comparison with standard].
Fazylov VKh; Manapova ÉR; Tkacheva SV; Sozinova IuM
Eksp Klin Gastroenterol; 2012; (6):96-9. PubMed ID: 23402198
[TBL] [Abstract][Full Text] [Related]
19. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
Iwasaki Y; Ikeda F; Yamamoto K
Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
[No Abstract] [Full Text] [Related]
20. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Chen YC; Lu SN; Lin MC
Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
